Summary: To evaluate the predictive role of the oncogene p53, the proliferating marker Ki-67, angiogenic factors platelet-derived endothelial cell growth factor/thymidine phosphorylase (PD-ECGF/dThdPase) and vascular endothelial growth factor (VEGF) in primary hypopharyngeal carcinoma, we immunohistochemically studied a series of 84 primary hypopharyngeal carcinoma patients who were treated at the Department of Otolaryngology of Kurume University Hospital between 1990 and 1997. The correlation of each score according to the intensity and percentage of the labeled cells with the TNM stage, histological grade, metastasis and survival status was analyzed. The positive rate of p53 was 52.4%. The percentages of Ki-67 labeled cells in patients with or without metastasis showed a significant difference (p=0.011). VEGF also showed a significant difference between the live and death groups (p<0.05) and also among the differentiation group (p<0.05). A statistically significant correlation was also seen between the score of p<0.001) or the score of Ki-67 and PD-ECGF (r=0.259, p<0.001), respectively. In conclusion, the present study suggests that a correlation exists between proliferating and angiogenesis, and VEGF and Ki-67 are thus considered to be possible prognostic discriminators in hypopharyngeal carcinoma.
INTRODUCTION
A number of molecules involved in the process of invasion and metastasis of cancer cells have been demonstrated to be biological prognostic parameters. An over expression of oncogenes (c-erbB, MDM2), an altered expression of suppressor genes (p53, p16, DCC) [1] [2] [3] , and an abnormal expression of adhesion molecules (E-cadherin) has been reported as markers of a high malignant potential. Proliferation markers (Ki-67, AgNORs, PCNA) [4] and angiogenetic factors (VEGF, PD-ECGF/dThdPase) [5] [6] [7] [8] are also related to the prognosis of the patients with various cancers including hypopharyngeal cancer.
In addition to the clinicopathological parameters, a combination of these biological markers may help to predict the clinical outcome of cases and to establish an individualized strategy of the treatment of each case according to the biological behavior of the cancer cells [9] . In order to evaluate the putative predictive value of p53, Ki-67, VEGF and PD-ECGF in relation to hypopharyngeal carcinoma, we studied their expressions in hypopharyngeal carcinoma and analyzed the results obtained in the cases.
MATERIALS AND METHODS

Patients and treatment
Eighty-four unselected hypopharyngeal carcino-ma specimens between 1990 and 1997 were obtained from the files of the Department of Otolaryngology, Kurume University Hospital. Any patients with either previous head and neck cancer or who had received radiation and chemotherapy before operation were ruled out. The age of the patients (75 males, 9 females) at diagnosis ranged from 43 to 83 years of age (average 62.4). The patients were stratified by tumor stage according to the TNM system of UICC (1987) . The surgical treatment included a total pharyngolaryngectomy, abilateral neck dissection and reconstruction using a free jejunal autograft and others. A few Ti or T2 patients were given a partial pharyngectomy. No patient had any evidence of distant metastasis at diagnosis. A postoperative pathologic analysis confirmed the existence of a sufficient surgical margins. After operation, radiotherapy for 30 to 60 Gy was given to most patients.
Imm unohistochemistry
All of the samples were routinely fixed in 10% buffered formalin and embedded in paraffin wax. For immunohistochemical staining, 4 um-thick sections were made on slides, deparaffinized and dehydrated in xylol with different degrees of alcohol. They were then rinsed in phosphate buffered saline (PBS). Regarding p53 and ki-67, antigenic retrieval was accomplished using a citrate buffer solution of pH 6 and then the tissue was heated in a microwave oven to enhance the sensitivity to antibody. The endogenous peroxidase activity was blocked using absolute methanol containing 0.3% H2O2 for 10 min.
After washing 3 times with PBS for 5 min, the sections were blocked by treating with PBS containing 1 % bovine serum albumin for 30 min. The blocked sections were incubated overnight at 4 °C with monoclonal antibody. The primary antibodies employed were DO-7 (p53), Ki-S5 (Ki-67) from DAKO (Lustrum Denmark), JH 121 (Ab-3 VEGF) from NeoMarkers (California, USA). The dilution of DO-7 and Ki-S5 were 1:25, of VEGF 1:50. Immunoperoxidase detection was employed by using the LASB method (K 0680, Dako LSAB Kit, HRP) as described previously. Counter-staining was performed using hematoxylin for 30 sec.
Criteria of judgment
The slides were viewed randomly without any knowledge of the patients' history. All slides were examined with a light microscope by the same investigator and given a score based on the intensity of the staining and the percentage of cells stained. 
Statistical analysis
The patients were stratified according to the tumor stage, survival and metastasis data which were correlated with the staining scores. The survival curve was calculated by the Kaplan-Meier life table method and the survival rate between each group was compared using the generalized Wilcoxon test. The effects of all histological parameters are analyzed by the Chi square test and Student's t test. Any correlations among groups of parameters were evaluated by Spearman Test and linear regression analysis. A p value of less than 0.05 (two side) was considered to indicate statistical significance.
RESULTS
Clinical assigns
Both within their stage groupings and overall, the patients were assigned to the following groups: "surviving group" (at least 3 year disease-free survival) n=34, "deceased group" (died of local or metastatic disease at anytime during the observation period) n=28. They were also assigned to "lymph metastasis" n=59, or "no lymph metastasis" n=25, and "early stage group" (stages I & II) n=16 or "late stage group (stages III & IV)" n=68, "T1-2 group" n=32 or a "T3-4 group" n=52. Histologically, squamous cell carcinomas were classified according to the standard criteria into well (n=28), moderately (n=50), or poorly differentiated carcinoma (n=6) with or without keratinization.
Immunohistological expression
The p53 expression was heterogeneous in most tumors, in which strongly positive areas and negative areas were alternatively combined. Of the 84 invasive tumors, 44 (52.4%) showed positive p53 immunostaining in the nucleus. The average percentage of p53 positive cells was 17.4% (ranging from 0 to 72%; median 3%). In even some normal mucosal area, there are positive cells at basement. No significance was found among the clinicopathological parameters and p53 staining intensity (Table 1) .
Ki-67 immunoreactivity appeared as diffuse or granular staining and was limited to the nucleus. If only a slight degree of cytoplasmic staining was observed, they were determined to be negative. Fiftyone cases were positive (60.7%). In some specimens, the glandular cells were found to be positive but the cancer cells were negative. The average percentages of the Ki-67 labeled cell index were 10.6% (ranging from 0 to 70%; median 7.3%). The percentages of Ki-67 labeled cells between the patients with and without metastasis were shown to be statistically significant (p=0.011, Table 2 ). The VEGF protein positive ratio obtained by (Table 4) .
Statistical results
The survival curves were determined by categorizing the population according to the staining results of each factor. The five years overall survival was thus found to be significantly worse in the VEGF positive group. However, when analysis was done of the five year disease free survival status, no significant difference was seen between the groups (Table  5 ). The demographic and clinicopathological characteristics were compared among p53, Ki-67, VEGF, PD-ECGF by the student's t test (two side). The results showed significant difference between survivor status and VEGF expression (Table 6) .
Both the chi square test and Student's t test were used for comparisons between the two groups with 
DISCUSSION
Tumor suppressor genes are thought to play a relatively more important role in head and neck tumor development than other oncogenes. The most commonly altered tumor suppressor gene in human cancer, as a whole, is the p53 gene. While p53 has been the subject of more extensive study than other tumor suppressor genes, its role or roles in the cancer pathway are still far from clear. Our study demon-strates the expression of p53 in a consistent proportion (52.4%) of invasive squamous cell carcinoma of the hypopharynx. Other investigators who found a range of p53 positive staining between 34% and 81% in head and neck cancer have been reported. In these studies, no correlation was found between protein over expression of p53 and sex, age, site of primary tumor, grade or level of differentiation of tumor, in accordance with our results [13] [14] [15] . Unal and others [16, 17] reported that p53 positivity statistically correlated with nodal metastasis and advanced tumor stage. Finding of p53 positivity in both primary and lymph nodes in metastatic cases also suggest that p53 mutations occur prior to metastases and promote metastatic potential of that clone of cells.
Ki-67 expression is lacking during the GO phase of the cell cycle and it is therefore currently used to immunohistochemically identify the proliferating rate in human tumors. Tumors with a high proliferating index are more aggressive and have a greater metastatic potential [12, 18] . Ki-67 negatively conelated with survival for all the stages, although there was no significant difference [14, 19] . In our study Ki-67 was positive at 42.5% and significantly conelated with lymph metastasis.
Vascular endothelial growth factor (VEGF) is a 34-42 kd protein that affects malignant tumors by promoting vasculogenesis, endothelial cell proliferation and migration, vascular permeability, tumor invasiveness, and angiogenesis [20] [21] [22] . Thymidine phosphorylase (dThdPase) is identical to plateletderived endothelial cell growth factor (PD-ECGF). dThdPase is known to promote the development of new blood vessels, which are fundamental to tumor growth and metastasis [23] [24] [25] . Angoogenesis is a risk factor of metastasis and recurrence and is also a prognostic indicator in human solid tumors. Our results suggest that VEGF and PD-ECGF are also involved in the angiogenesis in hypopharyngeal carcinoma because of their high expression (VEGF 75%, PD-ECGF 70%). However, PD-ECGF/dThdPase showed no significant relationship with the clinical parameters except for gender. A correlation between proliferating antigen and angiogenesis has been reported [20] . Our results showed a highly significant difference regarding positive expression between Ki-67 and VEGF or PD-ECGF.
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